0 Table of Contents |
1 Home |
2 Business Context |
3 Capability Statement |
4 Changelog |
5 Collect Measurements |
6 Complete Care Plan |
7 Consent Based Access Control |
8 Create Care Plan |
9 Create Condition |
10 Create Encounter |
11 Developer Guide |
12 Extensions |
13 Faq |
14 Fhir Consent |
15 Health Checks |
16 History |
17 In Home Observations |
18 Initial Assesment |
19 Roadmap |
20 Artifacts Summary |
20.1 Care In The Community ActivityDefinition Apply Operation |
20.2 Care In The Community PlanDefinition Apply Operation |
20.3 CommunicationPerson |
20.4 ManaakiNgaTahiAllergyIntolerance |
20.5 ManaakiNgaTahiCarePlan |
20.6 ManaakiNgaTahiCondition |
20.7 ManaakiNgaTahiDocumentReference |
20.8 ManaakiNgaTahiEncounter |
20.9 ManaakiNgaTahiObservation |
20.10 ManaakiNgaTahiPlanDefinition |
20.11 ManaakiNgaTahiServiceRequest |
20.12 ServiceRequestActivityDefinition |
20.13 Template for COVID-19 Care in the Community CCCM MVP Careplans |
20.14 Vital Signs Observation Service Request |
20.15 AIR - Overseas, Historic, Not Done |
20.16 Antiviral medication eligibility questionnaire |
20.17 COVID-19 RAT Result Questionnaire |
20.18 COVID19 Initial Health Assessment Questionnaire |
20.19 COVID19 Public Health History Questionnaire |
20.20 COVID19 Vaccination Side Effects Questionnaire |
20.21 Measles Daily Health Check |
20.22 Mental Health Assessment Survey |
20.23 Post Vaccine Symptom Check day 3 survey |
20.24 Post Vaccine Symptom Check day 42 survey |
20.25 Pregnancy Assessment Survey |
20.26 Question Template for COVID-19 Regular Health Check |
20.27 Report a Rapid Antigen Test (RAT) result |
20.28 ActiveMonitoringDay3SurveyQuestionnaireResponse |
20.29 ActiveMonitoringDay42SurveyQuestionnaireResponse |
20.30 AntiviralEligibilityNoQuestionnaireResponse |
20.31 AntiviralEligibilityYesQuestionnaireResponse |
20.32 ConsumerCOVIDRATResultQuestionnaireResponse |
20.33 COVIDInitialHealthAssessmentQuestionnaireResponse |
20.34 COVIDPublicHealthHistoryQuestionnaireResponseSherrylCarrion |
20.35 COVIDRATResultQuestionnaireResponse |
20.36 COVIDRegularHealthCheckQuestionnaireResponse |
20.37 COVIDVaccinationSurveyQuestionnaireResponse |
20.38 ImmsotVaccinationDataEntryQuestionnaireResponse |
20.39 MeaslesHealthCheckQuestionnaireResponse |
20.40 MentalHealthAssessmentSurveyQuestionnaireResponse |
20.41 PregnancyAssessmentSurveyQuestionnaireResponse |
20.42 CareyCarrington |
20.43 ConditionExample |
20.44 COVID-19 Omicron Response - Carey Carrington |
20.45 DocumentReferenceExample |
20.46 DrDottyMcStuffins |
20.47 EncounterExample |
20.48 ObservationExample |
20.49 ObservationsServiceRequestExample |
20.50 NIBSCommunicationPersonExample |
20.51 WhaihuaCommunicationPersonExample |
20.52 ActiveConsentExample |
20.53 ConsentByQuestionnaireExample |
20.54 ConsentByRelatedPersonExample |
20.55 ConsentExample |
20.56 ConsentQuestionnaireResponseExample |
20.57 ManaakiNgaTahiConsent |
20.58 ProvisionalConsentExample |
20.59 Question Template for COVID-19 Privacy Statement Question |
20.60 Shared Care FHIR Server Capability Statement |
20.61 HNZ Person Telecom Count Shared |
20.62 HNZ Person Telecom Information Source |
20.63 HNZ Person Telecom Invalid Indicator |
20.64 HNZ Person Telecom Last Contacted |
20.65 HNZ Person Telecom Phone Type |
20.66 HNZ Person Telecom Score |
20.67 COVID19 vaccines recognised by NZ public health |
20.68 Information source when using the telecom information source extension |
20.69 NZ purpose of use |
20.70 System that last updated the record |
20.71 Telecom phone type indicator |
20.72 Telecom record score indicator |
20.73 Codes for Telecom Phone Types |
20.74 Codes for Telecom Score |
20.75 Codes for Telecom Source Systems |
20.76 Codings for COVID-19 vaccination brands recognised in New Zealand public health |
20.77 AllergyIntoleranceExample |
20.78 Template for COVID-19 Care in the Community CCCM MVP Careplans |